Efficacy of pollen immunotherapy in seasonal allergic rhinitis

Pediatrics International

Volumn 49, Issue 1, 2007, Pages 64-69

  Can, Demet ^a,c   Tanaç, Remziye ^b   Demir, Esen ^b   Gülen, Figen ^b   Veral, Ali ^b  

^a Behcet Uz Children's Hospital   (Turkey)

^b EGE UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Allergic rhinitis; Immunotherapy; Nasal biopsy; Nasal peak inspiratory flow

Indexed keywords

GRASS POLLEN EXTRACT;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG EFFICACY; EOSINOPHIL COUNT; EYE DISEASE; FEMALE; GRASS POLLEN; HAY FEVER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOTHERAPY; MALE; MAST CELL; NASAL BIOPSY; NOSE DISEASE; NOSE SMEAR; POLLEN ALLERGY; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD;

ADOLESCENT; CHILD; DESENSITIZATION, IMMUNOLOGIC; EOSINOPHILS; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; NASAL MUCOSA; POLLEN; RHINITIS, ALLERGIC, SEASONAL; TREATMENT OUTCOME;

EID: 33846452146     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2007.02307.x     Document Type: Article

References (18)

1. International Consensus Report on diagnosis and management of rhinitis. International Rhinitis Management Working Group. Allergy 1994; 49 (19 Suppl.): 1-34.
2. Bousquet J. Allergic rhinitis and its impact on asthma (ARIA). J. Allergy Clin. Immunol. 2001; 108: 147-336.
3. Theodoropoulos DS, Lockey RF. Allergen immunotherapy: guidelines, update, and recommendations of the World Health Organization. Allergy Asthma Proc. 2000; 21: 159-66.
4. Meltzer EO, Malmstrom K, Lu S et al. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial. J. Allergy Clin. Immunol. 2000; 105: 917-22.
5. Leynadier F, Banoun L, Dollois B et al. Immunotherapy with a calcium phosphate-adsorbed five-grass-pollen extract in seasonal rhinoconjunctivitis: a double-blind, placebo-controlled study. Clin. Exp. Allergy 2001; 31: 988-96.
6. Wilson DR, Nouri-Aria KT, Walker SM et al. Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season. J. Allergy Clin. Immunol. 2001; 107: 971-6.
7. Tari MG, Mancino M, Ghezzi E, Frank E, Cromwell O. Immunotherapy with an alum-adsorbed Parietaria pollen allergoid: a 2 year, double-blind, placebo controlled study. Allergy 1997; 52: 65-74.
8. Gozalo F, Martin S, Rico P, Alvarez E, Cortes C. Clinical efficacy and tolerance of two year Lolium perenne sublingual immunotherapy. Allergol. Immunopathol. 1997; 25: 219-27.
9. Guvensen A, Ozturk M. Airborne pollen calendar of Izmir-Turkey. Ann. Agric. Environ. Med. 2003; 10: 37-44.
10. Guvensen A, Ozturk M. Airborne pollen calendar of Buca-Izmir, Turkey. Aerobiologia 2002; 18: 229-37.
11. Lim MC, Taylor RM, Naclerio RM. The histology of allergic rhinitis and its comparison to cellular changes in nasal lavage. Am. J. Respir. Crit. Care Med. 1995; 151: 136-44.
12. Benson M, Strannegard I, Strannegard Ö, Wennergren G. Topical steroid treatment of allergic rhinitis decreases nasal fluid Th2 cytokines, eosinophils, eosinophil cationic protein, and IgE but has no significant effect on IFN-γ, IL-β, TNF-α, or neutrophils. J. Allergy Clin. Immunol. 2000; 106: 307-12.
13. Nakamoto S, Ukai K, Sakakura Y. Effect of allergen immunotherapy on nasal responses in guinea-pigs with allergic rhinitis. Clin. Exp. Allergy 1997; 27: 1103-8.
14. Erel F, Karaayvaz M, Çalişkaner AZ et al. Effects of allergen immunotherapy on the nasal mucosa in patients with allergic rhinitis. J. Invest. Allergol. Clin. Immunol. 2000; 10: 14-19.
15. Wilson A, Dempsey OJ, Sims EJ, Lipworth BJ. Subjective and objective markers of treatment response in patients with seasonal allergic rhinitis. Ann. Allergy Asthma Immunol. 2000; 85: 111-14.
16. Wilson AM, Dempsey OJ, Sims EJ, Coutie JR, Paterson MC, Lipworth BJ. Evaluation of treatment response in patients with seasonal allergic rhinitis using domiciliary nasal peak inspiratory flow. Clin. Exp. Allergy 2000; 30: 833-8.
17. Walker SM, Pajno GB, Lima MT, Wilson DR, Durham SR. Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial. J. Allergy Clin. Immunol. 2001; 107: 87-93.
18. Wilson AM, Sims EJ, Orr LC et al. Effects of topical corticosteroid and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitis. Ann. Allergy Asthma Immunol. 2001; 87: 344-9.